Maureen Coleman


Maureen joined PIR’s Board in 2018 to support the strategic growth of the company; becoming NEC in June 2019 as part of the company restructuring. She brings a wealth of leadership and industry experience; both from her GSK career, ultimately as VP Global Strategy Development, and more recently in the early stage, entrepreneurial space.

Her portfolio includes founding CEO of NovaThera, Chair of Parafricta and CN Bio, founding Director of MedInnovate and founding industry consulting partner at Kinapse. Maureen’s life science knowledge, network, strategic insight and interest in developing people is invaluable to PIR and its strategic partners.